Comparative Effectiveness for AI MedTech
Published on: 04/09/2024
Why comparing your AI MedTech solution to the status quo isn’t enough for payer approval.
Evidence Planning
Why comparing your AI MedTech solution to the status quo isn’t enough for payer approval.
A review of what peer-reviewed publications reveal about payer adoption of AI tools.
Why U.S. reimbursement strategy should begin long before FDA approval if you want to survive.
MedTech teams often misunderstand what regulators mean. This article translates FDA and CMS jargon into actionable insights for reimbursement.